Articles

The TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits

The TGA has issued an infringement notice for $12,600 to Labtest Direct for the alleged advertising of COVID-19 Rapid Test kits

The Federal Court granted the interim injunction on 3 April 2020

The TGA has issued ATP Science Pty Ltd with 24 infringement notices

The TGA has issued Oxymed Australia Pty Ltd five infringement notices for alleged advertising breaches

The TGA will take action in relation to the illegal advertising of therapeutic goods, including those that make false and misleading claims about preventing or curing COVID-19

Due to changes in travel restrictions, all overseas GMP inspections and QMS audits have now been suspended until further notice

Community pharmacists to enforce new limits on dispensing and sales of prescription and over-the-counter medicines

Information for consumers

Stockpiling medicines may disrupt access to vital medicines by patients and pharmacies

The Secretary of the Department of Health has commenced proceedings in the Federal Court of Australia (Court) against Evolution Supplements Australia Pty Ltd

Xofluza approved as part of an international work-sharing initiative between the TGA, Health Canada and Swissmedic

Caruso's Natural Health pays $12,600 fine for false certification in relation to therapeutic good

Juice Plus Company Australia Pty Ltd has paid penalties of $37,800 for alleged advertising breaches relating to vitamin products

InSkin Cosmedics Group Pty Ltd has paid penalties of $37,800 in regards to the alleged supply and advertising of the Dermapen 4

Measles vaccine testing shows the vaccine meets required standards

Adequate stock available despite bushfires

Pharmacies and others can advertise availability of OTC salbutamol products during the bushfire season

Mundipharma Pty Ltd has paid penalties of $302,400 in response to 24 infringement notices issued by the TGA

Results of product testing

We will closely consider the judgment including any further improvements that could enhance the regulatory system in Australia.  

Acalabrutinib receives approval through the second international collaborative review initiative between the TGA, FDA and Health Canada

The TGA has joined the ICMRA and the WHO in a coordinated global approach to fighting antimicrobial resistance

Consumer Healthcare Products Australia to handle all medicine advertising pre-approval applications

The Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications